- Cerebrospinal fluid (CSF) biomarker results are highly supportive of sabirnetug’s downstream pharmacological effects in the brain in early AD...
Global Premiere Set for March 22 at Cinema Village in Greenwich Village, NYC ARLINGTON, Va., March 7, 2024 /PRNewswire/ --...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first...
MINNEAPOLIS, March 7, 2024 /PRNewswire/ -- People who have headaches after experiencing concussions may also be more likely to have...
Masimo Stork™ and Bowers & Wilkins Garner Six Prestigious Accolades Across Multiple CategoriesIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) is proud to...
Onsite Wellness House brings the best of Onsite and Milestones to those in Nashville and surrounding areas while minimizing disruption...
BOSTON and ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical...
MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses...
NEWTOWN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company...
On-track to report topline Phase 3 data from the KOASTAL-1 study with navacaprant in MDD in the second half of...
STOCKHOLM, SWEDEN / ACCESSWIRE / March 7, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
What: We Heart You: Recovery in Our Community EventWhen: Wednesday, March 13, 12:00-5:00 PM(Welcome at 12:30 PM, Keynote speaker from...
SANTA CLARA, CA / ACCESSWIRE / March 6, 2024 / Zeto, Inc., a commercial-stage medical technology company transforming EEG brain...
LAVAL, QC / ACCESSWIRE / March 6, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals,...
B Capital invests incremental $20M; previously raised $65M led by Novo Holdings with participation from existing investors Equity investment to...
Multiple DehydraTECH-GLP-1 and DehydraTECH-CBD formulations to be testedChronic dosing over a 12-week treatment periodWill assess weight loss and blood glucose...
TORONTO, ON / ACCESSWIRE / March 5, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
Dr. Roizen to provide expertise on longevity and aging Research on aging involving Telomir’s lead product candidate focused on reversing age-related...
Patients with Alzheimer’s Disease show improvement in brainwaves following 4 weeks of XPro™ therapy. Boca Raton, Florida, March 05, 2024...
- Neflamapimod led to significant reduction compared to placebo in plasma levels of glial fibrillary acidic protein (GFAP) - Neflamapimod...